APIRx-1803

N/A

Report date: 2025/03/14 18:10:54
NME

Base Information

Drug NameAPIRx-1803
Drug Alias NameCB1/CB2 modulator (APIRx Pharmaceutical)cannabidgerol (APIRx Pharmaceutical)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB2 receptor modulatorsCannabinoid CB1 receptor modulators
TargetsCannabinoid CB1 receptorCannabinoid CB2 receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAPIRx Pharmaceutical USA LLC
China Registration ClassN/A

Develop Information

Active CompaniesAPIRx Pharmaceutical USA LLC
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A